Comments
Illumina board rejects sweetened Roche offer
03.04.2012. | (Reuters) - Illumina Inc said on Monday that its board unanimously rejected Roche Holding's increased offer to buy the genetic sequencing company for $51 per share, or about $6.7 billion, saying it dramatically undervalued the company....
